A critical analysis of recent data on the long-term outcome of antipsychotic treatment

scientific article published on 19 December 2018

A critical analysis of recent data on the long-term outcome of antipsychotic treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0033291718003811
P698PubMed publication ID30563582

P50authorJoanna MoncrieffQ16732770
P2093author name stringSandra Steingard
P2860cites workShould psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?Q28109603
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational researchQ30692570
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).Q34018491
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 studyQ34051101
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.Q34075734
Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal studyQ34254903
Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trialsQ34441060
Antipsychotic treatment and mortality in schizophreniaQ35369872
The Long-Term Effects of Antipsychotic Medication on Clinical Course in SchizophreniaQ38803633
Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosisQ38918200
Long-term antipsychotic use and its association with outcomes in schizophrenia - the Northern Finland Birth Cohort 1966.Q39678156
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 studyQ43198845
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.Q52604209
Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.Q52650011
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?Q55023835
Early Medication Discontinuation on Long-term Recovery Outcome in First-Episode PsychosisQ57612290
Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care databaseQ89229446
P304page(s)1-4
P577publication date2018-12-19
P1433published inPsychological MedicineQ7256364
P1476titleA critical analysis of recent data on the long-term outcome of antipsychotic treatment

Reverse relations

cites work (P2860)
Q97521512Barriers to stopping neuroleptic (antipsychotic) treatment in people with schizophrenia, psychosis or bipolar disorder
Q103834527Misleading information about antipsychotics
Q95579730Protecting physical health in people with mental illness
Q90067070The association between family dysfunction and admission to an acute mental health inpatient unit: a prospective study

Search more.